Technical Analysis for ONVO - Organovo Holdings, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 1.15 | 2.68% | 0.03 |
ONVO closed up 2.68 percent on Thursday, April 18, 2024, on 47 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 20 DMA Support | Bullish | 2.68% | |
| Calm After Storm | Range Contraction | 2.68% | |
| Upper Bollinger Band Walk | Strength | 2.68% | |
| Upper Bollinger Band Touch | Strength | 2.68% |
| Alert | Time |
|---|---|
| Upper Bollinger Band Resistance | about 6 hours ago |
| 200 DMA Resistance | about 10 hours ago |
| Rose Above 200 DMA | about 11 hours ago |
| Up 10% | about 11 hours ago |
| Up 1 ATR | about 11 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/23/2024
Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications. The company's 3D NovoGen bioprinting technology works across various tissue and cell types, and allows for the placement of cells in desired pattern. It offers NovoGen MMX Bioprinter, a commercial hardware and software bioprinter platform to create tissues for bioprinting research and development. The company was founded in 2007 and is based in San Diego, California.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Biology Synthetic Biology Medical Applications Novogen Printing Technology Tissue Engineering
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Biology Synthetic Biology Medical Applications Novogen Printing Technology Tissue Engineering
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.09 |
| 52 Week Low | 0.8911 |
| Average Volume | 1,244,889 |
| 200-Day Moving Average | 1.24 |
| 50-Day Moving Average | 1.04 |
| 20-Day Moving Average | 1.06 |
| 10-Day Moving Average | 1.09 |
| Average True Range | 0.12 |
| RSI (14) | 56.33 |
| ADX | 45.08 |
| +DI | 45.55 |
| -DI | 11.70 |
| Chandelier Exit (Long, 3 ATRs) | 1.38 |
| Chandelier Exit (Short, 3 ATRs) | 1.35 |
| Upper Bollinger Bands | 1.22 |
| Lower Bollinger Band | 0.91 |
| Percent B (%b) | 0.78 |
| BandWidth | 29.13 |
| MACD Line | 0.03 |
| MACD Signal Line | 0.02 |
| MACD Histogram | 0.0136 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.45 | ||||
| Resistance 3 (R3) | 1.46 | 1.38 | 1.40 | ||
| Resistance 2 (R2) | 1.38 | 1.30 | 1.37 | 1.38 | |
| Resistance 1 (R1) | 1.26 | 1.25 | 1.32 | 1.25 | 1.37 |
| Pivot Point | 1.18 | 1.18 | 1.21 | 1.17 | 1.18 |
| Support 1 (S1) | 1.06 | 1.10 | 1.12 | 1.05 | 0.93 |
| Support 2 (S2) | 0.98 | 1.05 | 0.97 | 0.92 | |
| Support 3 (S3) | 0.86 | 0.98 | 0.90 | ||
| Support 4 (S4) | 0.85 |
